ASB10
Basic information
Region (hg38): 7:151175698-151187832
Previous symbols: [ "GLC1F" ]
Links
Phenotypes
GenCC
Source:
- glaucoma 1, open angle, F (Limited), mode of inheritance: Unknown
- glaucoma 1, open angle, F (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glaucoma 1, open angle, F | AD | Ophthalmologic | Open-angle glaucoma is typically asymptomatic until late stages, when irreversible nerve damage has already taken place; Agents that may contribute to glaucoma should be avoided | Ophthalmologic | 22156576 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (85 variants)
- not_provided (61 variants)
- Glaucoma_1,_open_angle,_F (43 variants)
- ASB10-related_disorder (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASB10 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001142459.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | |||||
missense | 103 | 17 | 128 | |||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 112 | 27 | 14 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASB10 | protein_coding | protein_coding | ENST00000420175 | 5 | 12135 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.64e-12 | 0.0204 | 125530 | 1 | 125 | 125656 | 0.000501 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.319 | 321 | 305 | 1.05 | 0.0000207 | 2920 |
Missense in Polyphen | 82 | 77.583 | 1.0569 | 815 | ||
Synonymous | -0.215 | 138 | 135 | 1.02 | 0.00000895 | 1070 |
Loss of Function | -0.320 | 17 | 15.6 | 1.09 | 9.15e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00128 | 0.00122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00341 | 0.00332 |
Finnish | 0.000731 | 0.000647 |
European (Non-Finnish) | 0.000197 | 0.000185 |
Middle Eastern | 0.00341 | 0.00332 |
South Asian | 0.000169 | 0.000163 |
Other | 0.000499 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.;
- Disease
- DISEASE: Glaucoma 1, open angle, F (GLC1F) [MIM:603383]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:22156576}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.0970
Intolerance Scores
- loftool
- 0.786
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.46
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.530
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asb10
- Phenotype
- hematopoietic system phenotype;
Gene ontology
- Biological process
- protein ubiquitination;intracellular signal transduction;post-translational protein modification
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function